Cargando…
LA inhalers for COPD: perceptions/reality of ABCD GOLD tool use
Background: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) created an ABCD tool to assess staging and severity of COPD subgroups that respond to LAMA or LABA with improved quality of life and reduced exacerbations. Our study assesses perception of physicians at five community hosp...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427455/ https://www.ncbi.nlm.nih.gov/pubmed/32850089 http://dx.doi.org/10.1080/20009666.2020.1786915 |
_version_ | 1783570880806256640 |
---|---|
author | Boryushkina, Varvara Kumar, Vikas Barnes, Martin Nabeel, Shaha Le, Thuy Siddique, Haseeb Haggerty, Greg Ng, Joseph Kaell, Alan |
author_facet | Boryushkina, Varvara Kumar, Vikas Barnes, Martin Nabeel, Shaha Le, Thuy Siddique, Haseeb Haggerty, Greg Ng, Joseph Kaell, Alan |
author_sort | Boryushkina, Varvara |
collection | PubMed |
description | Background: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) created an ABCD tool to assess staging and severity of COPD subgroups that respond to LAMA or LABA with improved quality of life and reduced exacerbations. Our study assesses perception of physicians at five community hospitals towards LAMA use for patients admitted with COPD exacerbations according to the GOLD guidelines and describes the experience at our hospital. Methods: Electronic survey forms regarding LAMA use and the GOLD criteria ABCD for COPD treating physicians were sent to five hospitals. A one-year chart review at our hospital determined prevalent use of a maintenance LAMA or LABA inhaler in patients admitted with acute COPD exacerbation. Currently, our EMR does not require a field for the GOLD ABCD categorization. Results: We obtained a 33% (45/136) response rate. Of these, 63% felt a LAMA to be essential on formulary; 60% were neutral or unlikely to initiate LAMA on admission; 47.7% likely or very likely to start a LAMA during hospitalization; 82% were neutral to very likely to discharge a patient on a LAMA if deemed necessary for maintenance. Of those admitted for acute COPD exacerbations to our hospital, over a third of COPD patients were not on a maintenance LAMA or LABA. Conclusions: Most physicians felt it important to prescribe a maintenance LAMA to COPD patients hospitalized for acute exacerbation. Our hospital’s use of LAMA or LABA demonstrates the need to incorporate strategies to encourage appropriate prescribing of these LA inhalers per GOLD guidelines. |
format | Online Article Text |
id | pubmed-7427455 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-74274552020-08-25 LA inhalers for COPD: perceptions/reality of ABCD GOLD tool use Boryushkina, Varvara Kumar, Vikas Barnes, Martin Nabeel, Shaha Le, Thuy Siddique, Haseeb Haggerty, Greg Ng, Joseph Kaell, Alan J Community Hosp Intern Med Perspect Brief Report Background: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) created an ABCD tool to assess staging and severity of COPD subgroups that respond to LAMA or LABA with improved quality of life and reduced exacerbations. Our study assesses perception of physicians at five community hospitals towards LAMA use for patients admitted with COPD exacerbations according to the GOLD guidelines and describes the experience at our hospital. Methods: Electronic survey forms regarding LAMA use and the GOLD criteria ABCD for COPD treating physicians were sent to five hospitals. A one-year chart review at our hospital determined prevalent use of a maintenance LAMA or LABA inhaler in patients admitted with acute COPD exacerbation. Currently, our EMR does not require a field for the GOLD ABCD categorization. Results: We obtained a 33% (45/136) response rate. Of these, 63% felt a LAMA to be essential on formulary; 60% were neutral or unlikely to initiate LAMA on admission; 47.7% likely or very likely to start a LAMA during hospitalization; 82% were neutral to very likely to discharge a patient on a LAMA if deemed necessary for maintenance. Of those admitted for acute COPD exacerbations to our hospital, over a third of COPD patients were not on a maintenance LAMA or LABA. Conclusions: Most physicians felt it important to prescribe a maintenance LAMA to COPD patients hospitalized for acute exacerbation. Our hospital’s use of LAMA or LABA demonstrates the need to incorporate strategies to encourage appropriate prescribing of these LA inhalers per GOLD guidelines. Taylor & Francis 2020-08-02 /pmc/articles/PMC7427455/ /pubmed/32850089 http://dx.doi.org/10.1080/20009666.2020.1786915 Text en © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group on behalf of Greater Baltimore Medical Center https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Brief Report Boryushkina, Varvara Kumar, Vikas Barnes, Martin Nabeel, Shaha Le, Thuy Siddique, Haseeb Haggerty, Greg Ng, Joseph Kaell, Alan LA inhalers for COPD: perceptions/reality of ABCD GOLD tool use |
title | LA inhalers for COPD: perceptions/reality of ABCD GOLD tool use |
title_full | LA inhalers for COPD: perceptions/reality of ABCD GOLD tool use |
title_fullStr | LA inhalers for COPD: perceptions/reality of ABCD GOLD tool use |
title_full_unstemmed | LA inhalers for COPD: perceptions/reality of ABCD GOLD tool use |
title_short | LA inhalers for COPD: perceptions/reality of ABCD GOLD tool use |
title_sort | la inhalers for copd: perceptions/reality of abcd gold tool use |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427455/ https://www.ncbi.nlm.nih.gov/pubmed/32850089 http://dx.doi.org/10.1080/20009666.2020.1786915 |
work_keys_str_mv | AT boryushkinavarvara lainhalersforcopdperceptionsrealityofabcdgoldtooluse AT kumarvikas lainhalersforcopdperceptionsrealityofabcdgoldtooluse AT barnesmartin lainhalersforcopdperceptionsrealityofabcdgoldtooluse AT nabeelshaha lainhalersforcopdperceptionsrealityofabcdgoldtooluse AT lethuy lainhalersforcopdperceptionsrealityofabcdgoldtooluse AT siddiquehaseeb lainhalersforcopdperceptionsrealityofabcdgoldtooluse AT haggertygreg lainhalersforcopdperceptionsrealityofabcdgoldtooluse AT ngjoseph lainhalersforcopdperceptionsrealityofabcdgoldtooluse AT kaellalan lainhalersforcopdperceptionsrealityofabcdgoldtooluse |